Most notably, NANOG decreased the prevalence of SA-β-Gal–positive myogenic progenitors and restored the number of these Pax7+ progenitors in the skeletal muscle of LAKI progeria mice in vivo. This evidence concerns the gene PAX7 and progeroid syndrome.